Literature DB >> 11172481

Glucose appearance rate after the ingestion of galactose.

M C Gannon1, M A Khan, F Q Nuttall.   

Abstract

Galactose is one of the monosaccharides of importance in human nutrition. It is converted to glucose-1-phosphate in the liver and subsequently stored as glycogen, or is converted to glucose and released into the circulation. The increase in plasma glucose is known to be modest following galactose ingestion. Whether this is due to a small increase in hepatic glucose output, or to a relatively large increase in hepatic glucose output but a concomitant increase in glucose disposal, is not known in humans. Therefore, the rates of glucose appearance (Ra) and disappearance (Rd) were determined over an 8-hour period in normal subjects using an isotope dilution technique. The subjects ingested 50 g galactose or water alone in random order at 8 AM on separate occasions. Plasma glucose, glucagon, lactate, urea nitrogen, total amino acids, and uric acid and serum insulin and triglycerides also were determined. Following galactose ingestion, there was a modest transient increase in peripheral glucose and insulin concentrations. This was associated with a modest increase in the glucose Ra. The calculated amount of glucose appearing in the circulation as a result of galactose ingestion was 9.8 g, while the amount of glucose disappearing over the 8 hours was 9.9 g. Thus, following ingestion of 50 g galactose by overnight-fasted men, approximately 20% appears as additional glucose in the circulation. Data obtained in animals suggest that a large amount of the galactose is stored as glucose in glycogen. Nevertheless, the conversion of galactose to glucose in the liver may have been greater than suggested by the increase in glucose appearance in the circulation due to substitution for other gluconeogenic substrates.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11172481     DOI: 10.1053/meta.2001.19442

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  6 in total

1.  The effect on glucagon, glucagon-like peptide-1, total and acyl-ghrelin of dietary fats ingested with and without potato.

Authors:  Angela Radulescu; Mary C Gannon; Frank Q Nuttall
Journal:  J Clin Endocrinol Metab       Date:  2010-05-05       Impact factor: 5.958

2.  Tolerable upper intake level for dietary sugars.

Authors:  Dominique Turck; Torsten Bohn; Jacqueline Castenmiller; Stefaan de Henauw; Karen Ildico Hirsch-Ernst; Helle Katrine Knutsen; Alexander Maciuk; Inge Mangelsdorf; Harry J McArdle; Androniki Naska; Carmen Peláez; Kristina Pentieva; Alfonso Siani; Frank Thies; Sophia Tsabouri; Roger Adan; Pauline Emmett; Carlo Galli; Mathilde Kersting; Paula Moynihan; Luc Tappy; Laura Ciccolallo; Agnès de Sesmaisons-Lecarré; Lucia Fabiani; Zsuzsanna Horvath; Laura Martino; Irene Muñoz Guajardo; Silvia Valtueña Martínez; Marco Vinceti
Journal:  EFSA J       Date:  2022-02-28

3.  Further decrease in glycated hemoglobin following ingestion of a LoBAG30 diet for 10 weeks compared to 5 weeks in people with untreated type 2 diabetes.

Authors:  Mary C Gannon; Frank Q Nuttall; Heidi Hoover
Journal:  Nutr Metab (Lond)       Date:  2010-07-29       Impact factor: 4.169

4.  Fragment Screening Reveals Starting Points for Rational Design of Galactokinase 1 Inhibitors to Treat Classic Galactosemia.

Authors:  Sabrina R Mackinnon; Tobias Krojer; William R Foster; Laura Diaz-Saez; Manshu Tang; Kilian V M Huber; Frank von Delft; Kent Lai; Paul E Brennan; Gustavo Arruda Bezerra; Wyatt W Yue
Journal:  ACS Chem Biol       Date:  2021-03-16       Impact factor: 5.100

5.  Effects of a carbohydrate supplement upon resting brain activity.

Authors:  Chenghua Wang; Joanne S Szabo; Roscoe A Dykman
Journal:  Integr Physiol Behav Sci       Date:  2004 Apr-Jun

6.  A Mechanistic Model of Intermittent Gastric Emptying and Glucose-Insulin Dynamics following a Meal Containing Milk Components.

Authors:  Priska Stahel; John P Cant; Jayden A R MacPherson; Harma Berends; Michael A Steele
Journal:  PLoS One       Date:  2016-06-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.